Haley CA, Schechter MC, Ashkin D, Peloquin CA, et al. Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for treatment of rifampin-resistant or rifampin-intolerant TB disease. Clin Infect Dis 2023 May 30:ciad312. doi: 10.1093.
PMID: 37249079